Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Harkin

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 23, 2006
Chronic fluoxetine treatment attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized ratMichelle Roche, Andrew Harkin, John P Kelly
Journal of Psychopharmacology (Oxford, England)|July 4, 2002
Reduction in preference for saccharin by repeated unpredictable stress in mice and its prevention by imipramineAndrew Harkin, Diarmaid D Houlihan, John P Kelly
The International Journal of Neuropsychopharmacology|January 18, 2016
Stress-Related Immune Markers in Depression: Implications for TreatmentMartina M Hughes, Thomas J Connor, Andrew Harkin
Physiology & Behavior|September 6, 2002
A study of VitalView for behavioural and physiological monitoring in laboratory ratsAndrew Harkin, James M O'Donnell, John P Kelly
Neuropharmacology|September 29, 2005
Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love")Ruth McNamara, Aoife Kerans, Barry O'Neill, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 28, 2004
Methylenedioxymethamphetamine suppresses production of the proinflammatory cytokine tumor necrosis factor-alpha independent of a beta-adrenoceptor-mediated increase in interleukin-10Thomas J Connor, Andrew Harkin, John P Kelly
Pharmacology & Therapeutics|December 3, 2011
The PSD-95/nNOS complex: new drugs for depression?Marika V Doucet, Andrew Harkin, Kumlesh K Dev
Journal of Psychopharmacology (Oxford, England)|March 23, 2026
Trip killers: Addressing a critical knowledge gap in psychedelic researchBrian O'Mahony, Colm Harrington, Andrew Harkin, et al.
British Journal of Pharmacology|September 12, 2019
Pharmacological targeting of β<sub>2</sub> -adrenoceptors is neuroprotective in the LPS inflammatory rat model of Parkinson's diseaseEoin O'Neill, Justin D Yssel, Caoimhe McNamara, et al.
The International Journal of Neuropsychopharmacology|March 11, 2014
Effects of brief pulse and ultrabrief pulse electroconvulsive stimulation on rodent brain and behaviour in the corticosterone model of depressionSinead O'Donovan, Victoria Dalton, Andrew Harkin, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 23, 2006
Chronic fluoxetine treatment attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized ratMichelle Roche, Andrew Harkin, John P Kelly
Journal of Psychopharmacology (Oxford, England)|July 4, 2002
Reduction in preference for saccharin by repeated unpredictable stress in mice and its prevention by imipramineAndrew Harkin, Diarmaid D Houlihan, John P Kelly
The International Journal of Neuropsychopharmacology|January 18, 2016
Stress-Related Immune Markers in Depression: Implications for TreatmentMartina M Hughes, Thomas J Connor, Andrew Harkin
Physiology & Behavior|September 6, 2002
A study of VitalView for behavioural and physiological monitoring in laboratory ratsAndrew Harkin, James M O'Donnell, John P Kelly
Neuropharmacology|September 29, 2005
Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love")Ruth McNamara, Aoife Kerans, Barry O'Neill, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 28, 2004
Methylenedioxymethamphetamine suppresses production of the proinflammatory cytokine tumor necrosis factor-alpha independent of a beta-adrenoceptor-mediated increase in interleukin-10Thomas J Connor, Andrew Harkin, John P Kelly
Pharmacology & Therapeutics|December 3, 2011
The PSD-95/nNOS complex: new drugs for depression?Marika V Doucet, Andrew Harkin, Kumlesh K Dev
Journal of Psychopharmacology (Oxford, England)|March 23, 2026
Trip killers: Addressing a critical knowledge gap in psychedelic researchBrian O'Mahony, Colm Harrington, Andrew Harkin, et al.
British Journal of Pharmacology|September 12, 2019
Pharmacological targeting of β<sub>2</sub> -adrenoceptors is neuroprotective in the LPS inflammatory rat model of Parkinson's diseaseEoin O'Neill, Justin D Yssel, Caoimhe McNamara, et al.
The International Journal of Neuropsychopharmacology|March 11, 2014
Effects of brief pulse and ultrabrief pulse electroconvulsive stimulation on rodent brain and behaviour in the corticosterone model of depressionSinead O'Donovan, Victoria Dalton, Andrew Harkin, et al.
Pageof 9